Can diabetes be cured by therapeutic cloning?

Pediatric Diabetes, Supplement

Volumn 5, Issue 2, 2004, Pages 79-87

  Ben Yehudah, Ahmi ^a   Witchel, Selma F ^a,b   Hyun, Sang Hwan ^a,d   Chaillet, J Richard ^c   Schatten, Gerald ^a,c  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d Chungbuk National University   (South Korea)

Author keywords

Differentiation; Insulin; Stem cells; Therapeutic cloning; Type 1 diabetes mellitus; cells

Indexed keywords

CYCLOSPORIN A; GLUCOSE; INSULIN; STEROID; TACROLIMUS;

ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; CELL CLONING; CELL DESTRUCTION; CELL NUCLEUS TRANSPLANTATION; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIABETES MELLITUS; EMBRYONIC STEM CELL; GINGIVA HYPERPLASIA; GRAFT VERSUS HOST REACTION; HUMAN; HYPERGLYCEMIA; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NEPHROTOXICITY; NEUROTOXICITY; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; STEM CELL TRANSPLANTATION; XENOTRANSPLANTATION;

EID: 11444256702     PISSN: 17451426     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-543x.2004.00083.x     Document Type: Review

References (88)

1. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA 2003: 290 (14): 1884-1890.
2. Centers for Disease Control and Prevention. National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2003. Atlanta, GA: U.S. Department of Health and Human Services. Centers for Disease Control and Prevention, 2003.
3. Engelgau MM, Geiss LS, Saaddine JB et al. The evolving diabetes burden in the United States. Ann Intern Med 2004: 140: 945-950.
4. Kahl A, Bechstein WO, Frei U. Trends and perspectives in pancreas and simultaneous pancreas and kidney transplantation. Curr Opin Urol 2001: 11: 165-174.
5. Ryan EA, Lakey JR, Paty BW et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002: 51: 2148-2157.
6. Paty BW, Ryan EA, Shapiro AM, Lakey JR, Robertson RP. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 2002: 51: 3428-3434.
7. Ahn KJ, Lee JW, Hahn ST et al. Diffusion-weighted MRI and ADC mapping in FK506 neurotoxicity. Br J Radiol 2003: 76: 916-919.
8. Veroux P, Veroux M, Puliatti et al. Tacrolimus-induced neurotoxicity in kidney transplant recipients. Transplant Proc 2002: 34: 3188-3190.
9. McKaig SJ, Kelly D, Shaw L. Investigation of the effect of FK506 (tacrolimus) and cyclosporine on gingival overgrowth following paediatric liver transplantation. Int J Pediatr Dent 2002: 12: 398-403.
10. Miller LW. Cardiovascular toxicities of immunosuppressive agents. Am J Transplant 2002: 2: 807-818.
11. Soria B, Skoudy A, Martin F. From stem cells to beta cells: New strategies in cell therapy of diabetes mellitus. Diabetologia 2001: 44: 407-415.
12. Murtaugh LC, Melton DA. Genes, signals, and lineages in pancreas development. Annu Rev Cell Dev Biol 2003: 19: 71-89.
13. Brivanlou AH. Stem cells. Setting standards for human embryonic stem cells. Science 2003: 300: 913-916.
14. Burdon T, Smith A, Savatier P. Signalling, cell cycle and pluripotency in embryonic stem cells. Trends Cell Biol 2002: 12: 432-438.
15. Lumelsky N. Differentiation of embryonic stem cells to insulin-secreting structures similar to pancreatic islets. Science 2001: 292: 1389-1394.
16. Ohsugi M, Cras-Meneur C, Zhou Y et al. Glucose and insulin treatment of insulinoma cells results in transcriptional regulation of a common set of genes. Diabetes 2004: 53: 1496-1508.
17. Gribble FM, Reimann F. Sulphonylurea action revisited: the post-cloning era. Diabetologia 2003: 46: 875-891.
18. Permutt MA, Koranyi L, Keller K et al. Cloning and functional expression of a human pancreatic islet glucose-transporter cDNA. Proc Natl Acad Sci USA 1989: 86: 8688-8692.
19. Roncero I, Alvarez E, Chowen JA et al. Expression of glucose transporter isoform GLUT-2 and glucokinase genes in human brain. J Neurochem 2004: 88: 1203-1210.
20. Matschinsky F, Liang Y, Kesavan P et al. Glucokinase as pancreatic beta cell glucose sensor and diabetes gene. J Clin Invest 1993: 92: 2092-2098.
21. Santer R, Groth S, Kinner M et al. The mutation spectrum of the facilitative glucose transporter gene SLC2A2 (GLUT2) in patients with Fanconi-Bickel syndrome. Hum Genet 2002: 110: 21-29.
22. Thomas PM, Cote GJ, Wohllk N et al. Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy. Science 1995: 268: 426-429.
23. Nestorowicz A, Inagaki N, Gonoi T et al. A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes 1997: 46: 1743-1748.
24. Stoffel M, Patel P, Lo YM et al. Missense glucokinase mutation in maturity-onset diabetes of the young and mutation screening in late-onset diabetes. Nat Genet 1992: 2: 153-156.
25. Hart LM, Dekker JM, van H aeften TW. Reduced second phase insulin secretion in carriers of a sulphonylurea receptor gene variant associating with type II diabetes mellitus. Diabetologia 2000: 43: 515-519.
26. Kulkarni RN, Bruning JC, Winnay JN et al. Tissue-specific knockout of the insulin receptor in pancreatic beta cells creates an insulin secretory defect similar to that in type 2 diabetes. Cell 1999: 96 (3): 329-339.
27. Kubota N, Tobe K, Terauchi Y et al. Disruption of insulin receptor substrate 2 causes type 2 diabetes because of liver insulin resistance and lack of compensatory beta-cell hyperplasia. Diabetes 2000: 49: 1880-1889.
28. Scearce LM, Brestelli JE, Mcweeney SK et al. Functional genomics of the endocrine pancreas: the pancreas clone set and PancChip, new resources for diabetes research. Diabetes 2002: 51: 1997-2004.
29. Jensen J. Gene regulatory factors in pancreatic development. Dev Dyn 2004: 229: 176-200.
30. Grapin-Botton A, Melton DA. Endoderm development - from patterning to organogenesis. Trends Genet 2000: 16: 124-130.
31. Wells JM. Genes expressed in the developing endocrine pancreas and their importance for stem cell and diabetes research. Diabetes Metab Res Rev 2003: 19: 191-201.
32. Herrera PL, Huarte J, Zufferey R et al. Ablation of islet endocrine-cells by targeted expression of hormone-promoter-driven toxigenes. Proc Natl Acad Sci USA 1994: 91: 12999-13004.
33. Kim SK, Hebrok M, Melton DA. Notochord to endoderm signaling is required for pancreas development. Development 1997: 124: 4243-4252.
34. Lammert E, Cleaver O, Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science 2001: 294: 564-567.
35. Kim SK, Hebrok M. Intercellular signals regulating pancreas development and function. Genes Dev 2001: 15: 111-127.
36. Hebrok M, Kim SK, Melton DA. Notochord suppression of endodermal Sonic hedgehog permits pancreas development. Genes Dev 1998: 12: 1705-1713.
37. Scharfmann R. Control of early development of the pancreas in rodents and humans: implications of signals from the mesenchyme. Diabetologia 2000: 43: 1083-1092.
38. Chiang MK, Melton DA. Single-cell transcript analysis of pancreas development. Dev Cell 2003: 4: 383-393.
39. Edlund H. Factors controlling pancreatic cell differentiation and function. Diabetologia 2001: 44: 1071-1079.
40. Hui H, Perfetti R. Pancreas duodenum homeobox-1 regulates pancreas development during embryogenesis and islet cell function in adulthood. Eur J Endocrinol 2002: 146: 129-141.
41. Grapin-Botton A, Majithia AR, Melton DA. Key events of pancreas formation are triggered in gut endoderm by ectopic expression of pancreatic regulatory genes. Genes Dev 2001: 15: 444-454.
42. Norgaard GA, Jensen JN, Jensen J. FGF10 signaling maintains the pancreatic progenitor cell state revealing a novel role of Notch in organ development. Dev Biol 2003: 264: 323-338.
43. Schwitzgebel VM, Schell DW, Conners JR et al. Expression of neurogenin3 reveals an islet cell precursor population in the pancreas. Development 2000: 127: 3533-3542.
44. Smith SB, Watada H, German MS. Neurogenin3 activates the islet differentiation program while repressing its own expression. Mol Endocrinol 2004: 18: 142-149.
45. Naya FJ, Huang HP, Qiu Y et al. Diabetes, defective pancreatic morphogenesis, and abnormal enteroendocrine differentiation in BETA2/NeuroD-deficient mice. Genes Dev 1997: 11: 2323-2334.
46. Wang J, Elghazi L, Parker SE et al. The concerted activities of Pax4 and Nkx2.2 are essential to initiate pancreatic β-cell differentiation. Dev Biol 2004: 266: 178-189.
47. Gu G, Wells JM, Dombkowski D, Preffer F, Aronow B, Melton DA. Global expression analysis of gene regulatory pathways during endocrine pancreatic development. Development 2004: 131: 165-179.
48. Jonsson J, Carlsson L, Edlund T, Edlund H. Insulin-promoter-factor 1 is required for pancreas development in mice. Nature 1994: 371: 606-609.
49. Stoffers DA, Zinkin NT, Stanojevic V, Clarke WL, Habener JF. Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence. Nat Genet 1997: 15: 106-110.
50. Gradwohl G, Dierich A, Lemeur M, Guillemot F. Neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. Proc Natl Acad Sci USA 2000: 97: 1607-1611.
51. Stoffel M, Vallier L, Pedersen RA. Navigating the pathway from embryonic stem cells to beta cells. Semin Cell Dev Biol 2004: 15: 327-336.
52. Wang J, Elghazi L, Parker SE et al. The concerted activities of Pax4 and Nkx2.2 are essential to initiate pancreatic beta-cell differentiation. Dev Biol 2004: 266: 178-189.
53. Shih DQ, Stoffel M. Molecular etiologies of MODY and other early-onset forms of diabetes. Curr Diab Rep 2002: 2: 125-134.
54. Hori Y, Rulifson IC, Tsai BC et al. Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci USA 2002: 99: 16105-16110.
55. Blyszczuk P, Czyz J, Kania G et al. Expression of Pax4 in embryonic stem cells promotes differentiation of nestin-positive progenitor and insulin-producing cells. Proc Natl Acad Sci USA 2003: 100: 998-1003.
56. Rajagopal J, Anderson WJ, Kume S, Martinez OI, Melton DA. Insulin staining of ES cell progeny from insulin uptake. Science 2003: 299: 363.
57. Sipione S, Eshpeter A, Lyon JG, Korbutt GS, Bleackley RC. Insulin expressing cells from differentiated embryonic stem cells are not beta cells. Diabetologia 2004: 47: 499-508.
58. Street CN, Lakey JRT, Seeberger K et al. Heterogeneous expression of nestin in human pancreatic tissue precludes its use as an islet precursor marker. J Endocrinol 2004: 180: 213-225.
59. Moritoh Y, Yamato E, Yasui Y, Miyazaki S, Miyazaki J-I. Analysis of insulin-producing cells during in vitro differentiation from feeder-free embryonic stem cells. Diabetes 2003: 52: 1163-1168.
60. Kahan BW, Jacobson LM, Hullett DA et al. Pancreatic precursors and differentiated islet cell types from murine embryonic stem cells: an in vitro model to study islet differentiation. Diabetes 2003: 52: 2016-2024.
61. Edlund H. Pancreatic organogenesis - Developmental mechanisms and implications for therapy. Nat Rev Genet 2002: 3: 524-532.
62. Hussain MA, Theise ND. Stem-cell therapy for diabetes mellitus. Lancet 2004: 364: 203-205.
63. Peck AB, Ramiya V. In vitro-generation of surrogate islets from adult stem cells. Transplant Immunol 2004: 12: 259-272.
64. Suzuki A, Nakauchi H, Taniguchi H. Prospective isolation of multipotent pancreatic progenitors using flow-cytometric cell sorting. Diabetes 2004: 53 (8): 2143-2152.
65. Holland AM, Gonez LJ, Harrison LC. Progenitor cells in the adult pancreas. Diabetes Metab Res Rev 2004: 20: 13-27.
66. Zorina TD, Subbotin VM, Bertera S et al. Recovery of endogenous β cell function in the NOD model of autoimmune diabetes. Stem Cells 2003: 21: 377-388.
67. Hess D, Li L, Martin M et al. Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol 2003: 21: 763-770.
68. Kodama S, Kuhtreiber W, Fujimura S, Dale EA, Faustman DL. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 2003: 302: 1223-1227.
69. Tang DQ, Cao LZ, Burkhardt BR et al. In vivo and in vitro characterization of insulin-producing cells obtained from murine bone marrow. Diabetes 2004: 53 (7): 1721-1732.
70. Lechner A, Yang YG, Blacken RA et al. No evidence for significant transdifferentiation of bone marrow into pancreatic beta cells in vivo. Diabetes 2004: 53: 616-623.
71. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic β-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004: 429: 41-46.
72. Wilmut I, Schnieke AE, McWhir J, Kind AJ, Campbell KH. Viable offspring derived from fetal and adult mammalian cells. Nature 1997: 385: 810-813.
73. Hochedlinger K, Jaenisch R. Nuclear transplantation, embryonic stem cells, and the potential for cell therapy. N Engl J Med 2003: 349: 275-286.
74. Rideout WM III, Hochedlinger K, Kyba M, Daley GQ, Jaenisch R. Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell 2002: 109: 17-27.
75. Perrier AL, Tabar V, Barberi T et al. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 2004 [Epub ahead of print].
76. Barberi T, Klivenyi P, Calingasan NY et al. Neural subtype specification of fertilization and nuclear transfer embryonic stem cells and application in parkinsonian mice. Nat Biotechnol. 2003: 21: 1200-1207.
77. Hwang WS, Ryu YJ, Park JH et al. Evidence of a pluripotent human embryonic stem cell line derived from a cloned blastocyst. Science 2004: 303: 1669-1674.
78. Bhushan A, Itoh N, Kato S et al. Fgf10 is essential for maintaining the proliferative capacity of epithelial progenitor cells during early pancreatic organogenesis. Development 2001: 128: 5109-5117.
79. Harrison KA, Thaller J, Pfaff SL, Gu H, Kehrl JH. Pancreas dorsal lobe agenesis and abnormal islets of Langerhans in Hlxb9-deficient mice. Nat Genet 1999: 23: 71-75.
80. Li H, Arber S, Jessell TM, Edlund H. Selective agenesis of the dorsal pancreas in mice lacking homeobox gene Hlxb9. Nat Genet 1999: 23: 67-70.
81. Lee YH, Sauer B, Gonzalez FJ. Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol 1998: 18: 3059-3068.
82. Hagenfeldt-Johansson KA, Herrera PL et al. β-cell-targeted expression of a dominant-negative hepatocyte factor-1a induces a maturity-onset diabetes of the young (MODY) 3-like phenotype in transgenic mice. Endocrinology 2001: 142: 5311-5320.
83. Jacquemin P, Durviaux SM, Jensen J et al. Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3. Mol Cell Biol 2000: 20: 4445-4454.
84. Sosa-Pineda B, Chowdhury K, Torres M, Oliver G, Gruss P. The Pax4 gene is essential for differentiation of insulin-producing β cells in the mammalian pancreas. Nature 1997: 386: 399-402.
85. Sussel L, Kalamaras J, Hratigan-O'Connor DJ et al. Mice lacking the homeodomain transcription factor Nkx2.2 have diabetes due to arrested differentiation of pancreatic β-cells. Development 1998: 125: 2213-2221.
86. Ramalho-Santos M, Melton DA, McMahon AP. Hedgehog signals regulate multiple aspects of gastrointestinal development. Development 2000: 127: 2763-2772.
87. Sander M, Neubuser A, Kalamaras J et al. Genetic analysis reveals that PAX6 is required for normal transcription of pancreatic hormone genes and islet development. Genes Dev 1997: 11 (13): 1662-1673.
88. Simerly C, Navara C, Hyun SH et al. Embryogenesis and blastocyst development after somatic cell nuclear transfer in non-human primates [nhp-scnt]: overcoming defects caused by meiotic spindle extraction. Developmental Biology 2004: 276: 237-252.